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IQCB1 and PDE6B Mutations Cause Similar Early Onset Retinal
Degenerations in Two Closely Related Terrier Dog Breeds
Abstract
Purpose.: To identify the causative mutations in two early-onset canine retinal degenerations, crd1 and crd2,
segregating in the American Staffordshire terrier and the Pit Bull Terrier breeds, respectively.
Methods.: Retinal morphology of crd1- and crd2-affected dogs was evaluated by light microscopy. DNA was
extracted from affected and related unaffected controls. Association analysis was undertaken using the
Illumina Canine SNP array and PLINK (crd1 study), or the Affymetrix Version 2 Canine array, the “MAGIC”
genotype algorithm, and Fisher's Exact test for association (crd2 study). Positional candidate genes were
evaluated for each disease.
Results.: Structural photoreceptor abnormalities were observed in crd1-affected dogs as young as 11-weeks
old. Rod and cone inner segment (IS) and outer segments (OS) were abnormal in size, shape, and number. In
crd2-affected dogs, rod and cone IS and OS were abnormal as early as 3 weeks of age, progressing with age to
severe loss of the OS, and thinning of the outer nuclear layer (ONL) by 12 weeks of age. Genome-wide
association study (GWAS) identified association at the telomeric end of CFA3 in crd1-affected dogs and on
CFA33 in crd2-affected dogs. Candidate gene evaluation identified a three bases deletion in exon 21 of PDE6B
in crd1-affected dogs, and a cytosine insertion in exon 10 of IQCB1 in crd2-affected dogs.
Conclusions.: Identification of the mutations responsible for these two early-onset retinal degenerations
provides new large animal models for comparative disease studies and evaluation of potential therapeutic
approaches for the homologous human diseases.
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PURPOSE. To identify the causative mutations in two early-onset canine retinal degenerations,
crd1 and crd2, segregating in the American Staffordshire terrier and the Pit Bull Terrier
breeds, respectively.
METHODS. Retinal morphology of crd1- and crd2-affected dogs was evaluated by light
microscopy. DNA was extracted from affected and related unaffected controls. Association
analysis was undertaken using the Illumina Canine SNP array and PLINK (crd1 study), or the
Affymetrix Version 2 Canine array, the ‘‘MAGIC’’ genotype algorithm, and Fisher’s Exact test
for association (crd2 study). Positional candidate genes were evaluated for each disease.
RESULTS. Structural photoreceptor abnormalities were observed in crd1-affected dogs as young
as 11-weeks old. Rod and cone inner segment (IS) and outer segments (OS) were abnormal in
size, shape, and number. In crd2-affected dogs, rod and cone IS and OS were abnormal as
early as 3 weeks of age, progressing with age to severe loss of the OS, and thinning of the
outer nuclear layer (ONL) by 12 weeks of age. Genome-wide association study (GWAS)
identified association at the telomeric end of CFA3 in crd1-affected dogs and on CFA33 in
crd2-affected dogs. Candidate gene evaluation identified a three bases deletion in exon 21 of
PDE6B in crd1-affected dogs, and a cytosine insertion in exon 10 of IQCB1 in crd2-affected
dogs.
CONCLUSIONS. Identification of the mutations responsible for these two early-onset retinal
degenerations provides new large animal models for comparative disease studies and
evaluation of potential therapeutic approaches for the homologous human diseases.
Keywords: retina, mutation, GWAS
Hereditary retinal degenerations (HRD) are blinding disor-ders characterized by dysfunction and death of rod and
cone photoreceptor cells. They are genetically and phenotyp-
ically heterogeneous, with causative mutations identified in 202
genes to date (RetNet; available in the public domain at https://
sph.uth.tmc.edu/retnet, 2013). This heterogeneity has signifi-
cant implications for gene discovery, not only because it is
critical to identify patients with the same mutation if causality is
to be resolved by large-scale association or case-control studies,
but also to enable gene therapy to be implemented in gene-
specific and even allele-specific manner.
We previously identified two early-onset autosomal recessive
retinal degenerations in American Staffordshire Terrier dogs
(AmStaff), and American Pit Bull Terrier dogs.1 In both diseases
very young dogs (less than 1-year old) were affected by severe
photopic and scotopic visual impairment, which progressed to
more severe blindness in early adulthood. Because of the similarity
of these two diseases, they were termed crd1 and crd2 (for cone–
rod dystrophy 1, and 2, respectively). For the same reason, and
because these two breeds of dog are physically similar and share
common ancestry, a cross-breeding complementation test was
undertaken to prove that the two diseases were nonallelic.
Candidate gene analysis excluded the genes ABCA41 and AIPL1,
GUCY2D,CRX,RDH5,CRB1,RDH12, TULP1,RPGRIP1,RPE65,
RDS, and HGR4 (Goldstein O, et al., IOVS 2005;46:ARVO E-
Abstract 3191) for both diseases. We now report results of
genome-wide association and subsequent studies that identify the
causative mutations for both diseases: a PDE6B deletion mutation
causing crd1, and an IQCB1 insertional mutation causing crd2.
METHODS
Animal Use
All procedures involving animal care were conducted in
accordance with the guidelines of the Institute for Laboratory
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Animal Research (Guide for the Care and Use of Laboratory
Animals); the United States Public Health Service (Public Health
Service Policy on Humane Care and Use of Laboratory Animals);
and the ARVO Resolution on the Use of Animals in Ophthalmic
and Vision Research.
Sample Collection
Blood was collected for DNA extraction from (1) 61 colony-
derived crd1-affected and unaffected dogs,1 including the
proband, a purebred crd1-affected AmStaff, (Fig. 1A, dogs 1–
61), (2) eight privately owned crd2-affected and nonaffected-
related purebred American Pit Bull Terrier dogs (Fig. 1B, dogs
1–5 and 29–31), and 50 colony-derived crd2-affected and
unaffected dogs1 (Fig. 1B, dogs 6–28 and 32–59), and (3) 110
privately owned pedigreed dogs from 19 breeds not known to
segregate crd1 or crd2 (Supplementary Table S1).
Clinical diagnoses were based on ophthalmoscopic exam-
inations, and in selected individuals by electroretinography, as
described previously.1
Morphologic Evaluation
From dogs selected for retinal morphologic examination, eyes
were enucleated and processed using a triple-fixative protocol
(3% glutaraldehyde-2% formaldehyde; 2% glutaraldehyde-1%
osmium tetroxide; and 2% osmium tetroxide) as previously
described.2,3 Evaluated dogs included: (1) crd1-and crd2-
affecteds at selected ages, doubly heterozygous dogs (i.e., dogs
heterozygous for both crd1 and crd2), (3) rcd1-affected dogs
(rcd1-affected dogs carry a PDE6B mutation, see further
discussion below), and (4) two progeny of a crd1xrcd1
crossbreeding.
After fixation, the posterior segment was trimmed into four
quadrants extending from the optic disc to the ora serrata.
Following dehydration, tissues were embedded in an epoxy
resin (polyBed 812; Polysciences, Warrington, PA), sectioned at
1 lm (Supercut 2065 microtome; Leica, Deerfield, IL), and
stained with azure II-methylene blue and a paraphenylenedi-
amine counterstain. For each dog, 1-lm sections extending
continuously from the optic disc to the ora serrata of superior,
inferior, and temporal meridians were evaluated by light
microscopy.
Genome-Wide Association Study (GWAS)
crd1. Group Design. Seventeen colony-derived-crd1-af-
fected dogs were selected that included one purebred AmStaff,
the colony proband (Fig. 1A, dog number 2). For the control
group, 18 unaffected-related dogs were selected. Dogs were
chosen based on DNA availability and quality, relatedness, and
parental and offspring trios for future analysis, if needed (Fig.
1A, dogs colored in blue).
SNP Genotyping. Samples were assayed using the Illumina
HD Canine array, which genotypes 173662 SNP loci, following
the manufacturer’s standard protocol (Illumina, Inc., San
Diego, CA). Genotypes were called using the GenomeStudio
algorithm (Illumina, Inc.).
Association Analysis. Genotype calls were converted into a
Plink-format file and association was tested using the PLINK4
association command without pedigree or sex information
(available in the public domain at http://pngu.mgh.harvard.
edu/purcell/plink/). Genotype calls for canine chromosome 3
(CFA3) were retrieved from the files and assembled into a
haplotype to identify the minimal Linkage Disequilibrium (LD)
interval and the homozygosity block.
Homozygosity Blocks Analysis. This analysis was undertak-
en on affected dogs only (n ¼ 17) using Plink, with the
following criteria: sliding window criteria: 1000 Kb, 50 SNPs, 5
missing calls, 1 heterozygous call, 0.05 threshold; homozygous
segment criteria: 1000 Kb length, 100 SNPs, 50 density (Kb/
SNP). The output was then filtered for chromosomes where at
least 16 animals showed a minimum of one homozygous
segment anywhere in the chromosome. The segments were
then aligned for each chromosome, to identify those where at
least 16 dogs shared a homozygous block. For such regions,
genotype calls were retrieved to evaluate if all homozygous
blocks were homozygous for the same haplotype. If so, then
the haplotypes were compared with those observed in the
control group.
crd2. Group Design. A total of 15 crd2-affected and 13
unaffected dogs were selected, including: (1) Three purebred
crd2-affected dogs and two purebred obligate crd2-heterozy-
gotes (Fig. 1B, dogs 1–5), and (2) 12 crd2-affected and 11
obligate crd2-heterozygous colony dogs (Fig. 1B, dogs 6–28).
Affected dogs were chosen to be the least related to each other
(no siblings) within the expanded colony-derived pedigree.
SNP Genotyping. Samples were assayed using the Affyme-
trix canine SNP genotyping array version 2, which genotypes
approximately 127000 SNP loci. The standard Affymetrix
GeneChip Mapping 250K Sty Assay protocol was followed,
using 250 ng genomic DNA. Genotypes were called using the
MAGIC algorithm5 based on the intensity values contained in
the Affymetrix CEL files.
Association Analysis. Genotype calls for SNPs that passed
the MAGIC quality control filters were then tested for
association with the disease phenotype, using Fisher’s exact
test as follows. First, under or overrepresentation of disease
phenotype was evaluated for all samples called homozygous
for one of the SNP’s two alleles (i.e., ‘‘allele 1’’), in comparison
to all other samples (i.e., a pooled class combining homozy-
gotes for ‘‘allele 2’’ with all those called heterozygous). Then
the test was repeated, comparing homozygotes for ‘‘allele 2’’
with all other samples, in this case, the pooled class combined
homozygotes for ‘‘allele 1’’ with the heterozygotes. A
Bonferroni correction for multiple tests was used to set the
significance threshold at Log10(P) ‡ 6.39 [0.05/(60245*2)], a
highly conservative approach given the correlated tests and the
conservative nature of this correction. Genotype calls for
CFA33 were retrieved from the files and assembled into a
haplotype to identify the minimal LD interval and the
homozygosity block.
Homozygosity Blocks Analysis. This analysis was undertak-
en on affected dogs only (n ¼ 14) using Plink, with the
following criteria: sliding window criteria: 50 Kb, 5 SNPs, 5
missing calls, 0 heterozygous calls, 0.05 threshold; homozy-
gous segment criteria: 1000 Kb length, 20 SNPs, 50 density
(Kb/SNP). The output was then filtered for those chromo-
somes where at least 13 animals showed a minimum of one
homozygous segment. The segments were then aligned to
identify chromosomes where at least 13 dogs shared a
homozygous block. For such regions, genotype calls were
retrieved to evaluate if all homozygous blocks were homozy-
gous for the same haplotype.
Candidate Gene Analysis. For both crd1 and crd2 studies,
RNA was extracted from the retinas of both a 12-week-old
affected dog and a healthy dog as previously described,6
affected and normal sequences were compared using Se-
quencher 4.2.2 Software (Gene Codes Corporation, Ann Arbor,
MI).
crd1. Within the identified homozygous block, the gene
Phosphodiesterase 6B (PDE6B) was the outstanding candidate
because of its known importance to phototransduction,7,8 and
its previous causal association with hereditary retinal degen-
erations.9–11 This gene was screened by retinal-cDNA PCR
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FIGURE 1. Canine pedigrees segregating crd1 and crd2. Solid symbols ¼ affected; half-filled ¼ unaffected obligate heterozygotes; empty ¼
unaffected, either carriers or homozygous normal. Blue¼ animals genotyped on a SNPchip array for genome wide association study, as well as for
the identified crd1 or crd2 mutation. Black numbered¼dogs genotyped for informative SNPs and the mutation for linkage analysis. Arrows indicate
the propositi for the mixed breed crd1 and crd2 colonies, and the respective informative pedigrees. (A) A crd1-affected AmStaff (dog 2, arrow) was
bred to a homozygous normal dog (dog 1). All F1 pups were unaffected. Heterozygous offspring were intercrossed to generate informative litters.
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amplification (Supplementary Table S2Ai). The mutation was
confirmed by genomic-DNA-PCR of an affected, a carrier, and a
healthy dog, followed by sequencing validation (Supplementa-
ry Table S2Aii). An allele-specific extension test to screen 105
dogs from 18 breeds (Supplementary Table S1) was then
designed as: (1) a primer pair including a forward primer
specific to the wild-type allele, to amplify a 186 bp fragment
(the normal allele), and (2) a separate primer pair including a
mutant-allele-specific reverse primer with a deliberate mis-
match in the 30 penultimate base, to amplify a 362 bp fragment
(the mutant allele) (Supplementary Table S2Aiii).
crd2. Within the identified homozygous block, the gene
‘‘IQ calmodulin-binding motif-containing protein 1’’ (IQCB1,
also known as NPHP5) was the outstanding candidate because
of its previously identified causal association with human
hereditary retinal degeneration syndromes.12–14 This gene was
evaluated by exon scanning on genomic DNA (Supplementary
Table S2Bi) and by amplification of the coding sequence from a
normal and an affected retinal cDNA (Supplementary Table
S2Bii). Mutation screening was done by either direct sequenc-
ing using the Applied Biosystems Automated 3730 DNA
Analyzer (Applied Biosystems, Foster City, CA; Supplementary
Table S2Biii, primer pair 1) or by performing an allele-specific
extension test using a specific reverse primer for each allele
(Supplementary Table S2Biii, primer pairs 2 and 3). Primer pair
2 identifies the wild-type allele and amplifies a 225 bp
fragment; primer pair 3 identifies the mutated allele and
amplifies a 226 bp fragment. Polymerase chain reaction
products were visualized on a 1.8% agarose gel stained with
Ethidium Bromide using standard protocols.
Linkage Analysis
Linkage analysis was run using informative pedigrees of colony-
derived dogs for each disease, using MultiMap15 as previously
described.6,16
crd1. One informative SNP (rs23644636) and the identified
PDE6B mutation, were both genotyped on an extended set of
dogs (23 affected, 26 obligate heterozygotes, 9 unaffected, and
3 healthy, Fig. 1A dogs 1–61).
crd2. Seven dogs from the purebred study pedigree and 52
dogs from the colony segregating the disease were genotyped
for a SNP on chromosome 12 (rs22195986) and for the
identified IQCB1 mutation (Fig. 1B, dogs 1–59).
RNA Expression
RNA was extracted from the retinas of: (1) a 12-week-old crd1-
affected dog, (2) 2.9-, 5.0- and 12.3-week-old crd2-affected
dogs, and (3) 3.3-, 4.3-, 8.6-, 10.4-, 12-week-old healthy dogs,
and from the spleen of a 22.1-week-old healthy dog. Total RNA
membranes were generated as previously described17 from
crd2-unaffected and affected retinas. An IQCB1 probe was
produced by amplification of normal retinal cDNA using
primer pair 5 in Supplementary Table S2Bii (exon 13 to 30
UTR). The product was then cloned (TOPO TA cloning kit;
Invitrogen, Carlsbad, CA), and used for blot hybridization.
Hybridization was carried out using Ultrahyb solution (Am-
bion, Austin, TX) following the manufacturer’s protocol. The
Blot was exposed to X-ray film at 708C for 11 days with two
intensifying screens. Loading control was achieved by hybrid-
izing a canine-specific beta-actin probe to the membranes
under the same conditions and exposed to X-ray film for 4 to 6
hours.
PDE6B Compound-Heterozygosity Analysis
Because rod–cone dysplasia type 1 (rcd1) in Irish Setter dogs is
caused by a previously described nonsense mutation in
PDE6B,18 a crd1-affected dog was crossbred to an rcd1-
affected dog to produce compound-heterozygous progeny.
Retinal morphologic evaluation was undertaken, as described
above, on eyes from two such pups aged 10 weeks.
RESULTS
Morphology
In the healthy retina at 3-weeks postnatal age the photorecep-
tor nuclei were individually mostly spindle shaped and formed
an outer nuclear layer (ONL) that was approximately 12- to 15-
nuclei thick. The nascent inner segment layer (ISL) had
formed, with cone inner segments larger but less numerous
than those of rods. Few if any outer segments had yet
developed (Fig. 2A).
By 14-weeks postnatal age, the healthy canine retina ONL
was 10- to 11-nuclei thick, and the photoreceptor inner (IS)
and outer (OS) segments were well developed, uniformly
elongate and arrayed in serried layers (Fig. 2B).
crd1. At 11-weeks postnatal age, the earliest time-point
examined, the ONL of the crd1-affected retina was reduced to
between 6 to 8 nuclei in thickness (Fig. 2C). Photoreceptor IS
and OS were distinctly distorted, with rod IS more severely
affected than those of cones. Relatively few OS of either rods or
cones were recognizable, and the profiles that comprised the
putative ISL and OSL (i.e., the layer between the outer limiting
membrane and the RPE) were sparse and disarrayed (Fig. 2C).
By 20 months of age, the crd1-affected retina was in an
advanced state of degeneration, with less than 2 to 3 ONL cells
(Fig. 2D).
Retinas of compound heterozygous (rcd1/crd1) dogs,
examined at 10-weeks postnatal age were affected by a
degenerative disease very similar to that of an rcd1-homozy-
gous affected dog at approximately the same age: the rcd1/
crd1 ONL was 4- to 5-nuclei thick (Fig. 2E) compared with 3 to
4 in rcd1 (Fig. 2F), and in both cases the ISL and OSL had IS and
OS that were similarly and severely reduced in both number
and size (Figs. 2E, 2F). In comparison, the 11-week-old crd1-
affected retina (Fig. 2G), although distinctly degenerate, had an
ONL that was between 6 to 8 nuclei in thickness, representing
approximately twice as many remaining photoreceptors as in
either the rcd1/crd1 or rcd1 retina. Similarly, although the ISL
and OSL of the crd1-affected retina were distinctly degenerate
at this age, they were also distinctly better preserved than in
either the rcd1/crd1 or rcd1 retina.
crd2. At 3.3-weeks postnatal age, the earliest time-point
examined, the crd2-affected retina (Fig. 2H) had developed to a
stage similar to that of the age-matched healthy retina (Fig. 2A).
In particular, the number of cells in the ONL of the crd2-
affected retina did not appear to be reduced. However, the ISL
appeared a little less well developed than in the healthy
control, and few if any OS were apparent.
By 12 weeks of age, (Fig. 2I), the ONL of the crd2-affected
retina comprised only 5 to 7 layers; cone and rod IS and OS
(B) A crd2-affected American Pit Bull Terrier (dog 3, arrow) was bred to 2 homozygous healthy dogs (32, 33). All F1 pups were unaffected.
Heterozygous offspring were intercrossed or backcrossed to generate informative litters. Dogs 1, 2, 4, 5, 29, 30, and 31 are purebred Pit bull terrier
dogs, relatives of the affected founder of the mixed-breed crd2 colony.
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FIGURE 2. Light microscopic retinal morphology in healthy (row 1); crd1 (row 2); crd1xrcd1, rcd1, and crd1 (row 3); and crd2 affected dogs (row
4). (A) Retina of a 3-week-old healthy dog. Photoreceptor nuclei are mostly spindle shaped, forming an ONL approximately 12- to 15-nuclei thick. A
nascent ISL has formed, with cone inner segments larger, but less numerous than those of rods. Few, if any, photoreceptor OS are detectable. (B)
Retina of a 14-week-old healthy dog. The ONL comprises approximately 10 to 11 rows of rod nuclei and a single outermost row of cone nuclei.
Photoreceptor IS and are of consistent proportions, tightly aligned, and orientated in parallel. (C) Retina of an 11-week-old crd1-affected dog. The
ONL is only 5- to 7-layers thick. Inner segments are severely distorted, disorganized, and loosely packed, with cone IS less damaged than those of
rods. Few, if any, OS are present. (D) Retina of a 20-month-old crd1-affected dog. Severe degeneration is evidenced by loss of rod and cone IS, OS,
and nuclei. (E) Retina of a 10-week-old rcd1xcrd1 compound heterozygous dog. Degeneration, as evidenced by reduction of the ONL to 4 to 5 layers
and absence of IS and OS, is much more severe than in the age matched crd1-affected (see [B, G]), and similar to the age-matched rcd1-affected
retina (F). (F) Retina of a 14-week-old rcd1-affected dog. Outer nuclear layer is thinned to 3 to 4 layers, with no evidence of IS and OS. Degeneration
is much more severe than in the age-matched crd1-affected (see [B, G]). (G) Retina of an 11-week-old crd1-affected dog for comparison with (E) and
(F). (H) Retina of a 3-week-old crd2-affected dog. Broadly similar to age-matched healthy (A). Photoreceptor nuclei in the ONL are broadly similar to
age-matched healthy (A), but IS are less well developed and OS are not apparent. (I) Retina of a 12-week-old crd2-affected dog. The ONL comprises
only 6 to 7 layers; cone and rod IS and OS are present but abnormal, disorganized, and much reduced in number compared with an age-matched
healthy retina (B). (J) Retina of a 20-month-old crd2-affected dog. No IS and OS are present, and the ONL is thinned to less than 1- to 2-cell layers.
Scale bars: 10 lM.
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were present but distinctly abnormal, disorganized, and
reduced in size and number compared with age-matched
healthy retinas (Fig. 2B). At 20 months of age, no IS and OS
were present in the crd2-affected retina, and the ONL was
thinned to nowhere more than 2 cell layers (Fig. 2J).
In comparing different retinal regions of the same crd2-
affected dog, and retinas of different crd2-affected dogs at the
same age, it emerged that the stage of development and or
degeneration was not always consistent either between
regions, or between dogs. In particular, there were sometimes
local regions where the retina was either markedly better
developed or preserved, or less degenerate, than in other
regions of the same eye, or compared with another age-
matched affected retina. For example, at 3.3-weeks postnatal
age, although the crd2-affected retina in the superior (Fig. 3A)
and inferior quadrants (Fig. 2H) shows little IS and essentially
no OS development, there is markedly more advanced
development of both IS and OS in the temporal quadrant
(Fig. 3B). In the latter region a minority of rods had developed
outer segments, compared with none in the superior and
inferior quadrants (Figs. 3B, 2H). A similar difference was
observed in the retina of a 12-week-old crd2-affected retina. In
the superior quadrant of this eye (Fig. 3C), the retina is
distinctly more degenerate and less well developed than in the
temporal quadrant (Fig. 3D), where cones are more numerous,
and rod IS and OS, although strangely disarrayed, are much
better preserved, or developed. However, these differences do
not persist and by 34 weeks of age both central and temporal
sections are showing severe degeneration of rods and cones
(Figs. 3E, 3F), and this more uniform degeneration continues at
later ages (Fig. 2J).
Double Heterozygous Analysis. Prior to identification of
the crd1 and crd2 mutations, a crd1-affected dog (Fig. 1A, dog
number 2) was bred to a crd2-heterozygous dog (Fig. 1B, dog
number 11) as a test for allelism, and produced 8 phenotyp-
ically healthy progeny.1 We subsequently bred a crd1-hetero-
zygous dog to a crd2-affected dog, obtaining five further
progeny. Once the crd1 and crd2 mutations were identified,
these 13 dogs were genotyped for both mutations, to identify
six dogs that were heterozygous for both the crd1 and the crd2
FIGURE 3. Light microscopic retinal morphology in crd2-affected dogs exhibiting relative preservation or enhanced development at different ages
and between different retinal quadrants. (A, C, E) Superior quadrant (central region, ~midway from optic nervehead to ora serrata). (B, D, F)
Temporal quadrant (central region, ~midway from optic nervehead to ora serrata). (A, B) Retinas from 3-week-old crd2-affected dogs. Compare also
with Figure 2H. Although the ONL is significantly thicker in the superior quadrant (A), IS and OS development is distinctly better preserved in the
temporal quadrant (B). (C, D) Retinas from 12-week-old crd2-affected dogs. Compare also to Figure 2I. Preservation of the OS is noticeably better in
the temporal quadrant (D), where the IS are more tightly organized and more cones are present, than in the central region (C) with its relatively
sparse OSL and disorganized ISL. (E, F) Retinas from 34-week-old crd2-affected dogs. At this age the differences between the central (E) and
temporal (F) quadrants are less noticeable, with more severe degenerative changes across the retina. Scale bars: 10 lM.
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mutations. Clinical and ophthalmoscopic evaluation of these
dogs showed no evidence of vision impairment or retinal
abnormality. Retinal morphologic evaluation in two of these
dogs at 20-weeks postnatal age found no pathologic changes
(data not shown).
Genome-Wide Association Study
crd1. Thirty-five dogs were genotyped for the 173662 SNPs
on the HDCanine-Illumina-array. Thirty of these dogs had both
parents represented in the experiment, and four dogs had only
one parent. The proband, dog number 3 in Figure 1A, had
neither parent analyzed. Analysis of genotype calls determined
the heritability frequency at 0.9998 for both one-parent- and
two-parents-genotyped cases, and the average number of errors
was 24.8 SNPs (Supplementary Table S3). Genotype calls were
converted to Plink-formatted files and association analysis was
run comparing the 17 affected dogs to the 18 controls. The
highestLog10(P) value was 5.764, observed in seven SNPs on
CFA3, in the interval 93927492-94484373 (Table 1; Fig. 4A). All
affected dogs were homozygous for the same allele in each of
these seven SNPs, while all the unaffected dogs were
heterozygous, supporting recessive inheritance as suggested
by pedigree analysis. All CFA3 genotype calls were then
aligned, to identify a homozygous block where all affected dogs
were homozygous for the same haplotype and all controls were
not. A 1.05 Mb homozygous block was observed from
93639445-to the telomeric end of CFA3 represented by a
SNP located at 94693816 and included 88 SNPs (Supplemen-
tary Table S4A). Within this block, SNP rs23644636 (CFA3:
94607062) was genotyped on the extended crd1-derived
colony pedigree (Fig. 1A, dogs 1–61). Complete linkage was
observed between the SNP and the disease, and a lod score of
13.847 where theta equals 0.00 was obtained.
crd2. Of the approximately 127000 loci on the Affymetrix
SNP chip, genotype calls for 60245 passed quality control
testing filters of the algorithm ‘‘MAGIC.’’ Genotype calling for
one affected sample did not pass quality control and was not
further used in the analysis (dog 16 in Fig. 1B). The Fisher
exact test ran on 14 affected and 13 obligate-heterozygous
samples yielding two hits: one to chromosome 33 and one to
chromosome 12 (Table 2; Fig. 4B), the latter with lower P
values. The peak Log10(P) value of 6.126 was shared by five
SNPs, all located within a 4.4 Mb interval on CFA33 (22690750-
27122415). None of the SNPs passed genome-wide significance
thresholds (Log10[P] > 6.39). All 14 affected dogs were
homozygous for these SNPs as was one obligate-heterozygote
(dog number 2 in Fig. 1B, a purebred Pit Bull Terrier). The
remaining 12 obligate-heterozygotes in the control group were
heterozygous for all five SNPs. This supported recessive
inheritance as suggested from pedigree analysis, except for
dog 2. Accordingly, all genotype calls on CFA33 were aligned to
identify a homozygosity block, where all affected were
homozygous for the same haplotype and all controls were
not (Supplementary Table S4B). Three such regions were
identified. The proximal block, 0.273 Mb long (22519503-
22792968) comprised genotypes for eight SNPs, and included
one of the five most significant SNPs (CFA33: 22690750) and
only one refseq gene (GAP34). Another homozygous block at
CFA33: 24222713-24890251, a 0.667 Mb interval, included 31
SNPs, three of which had the highest P value, but no refseq
genes. The most distal block was 2.67 Mb long (CFA33:
26786412-29463543), comprised 47 SNPs, one of which had
the highest P value, included four refseq genes (COX17, CD86,
CASR, and ADCY5) and more than 15 non-refseq genes that are
expressed in the eye. Except for dog number 2, all dogs in the
control group were heterozygous for all SNPs in all three
‘‘homozygosity blocks.’’ Dog number 2 was homozygous for
the same haplotype as its affected offspring, dog number 3, for
an 18 Mb interval on CFA 33 (data partially shown in
Supplementary Table S4B for the interval 22512 990-
29709462).
The same analysis was applied to the second hit on CFA12.
Haplotype analysis showed that within the significant region,
two affected animals were heterozygous through the whole
interval (approximately 8 Mb interval), and one control dog
was homozygous to the affected haplotype (data not shown).
To further assess this hit, a SNP within this interval
(rs22195986, CFA12: 3865659, log10[P] ¼ 4.162; Table 2)
was genotyped in a larger crd2-informative pedigree and
linkage analysis undertaken. A lod score of 0.738, at theta
equals 0.406 indicted this CFA12 hit as a false positive.
Homozygosity Analysis
To evaluate the power of homozygosity analysis in simple
Mendelian recessive diseases, we analyzed the calls from
affected dogs only (17 crd1-affected dogs and 14 crd2-affected
dogs), and looked for homozygous blocks that are greater than
1.0 Mb in each disease separately. We did not analyze the sex
chromosomes.
crd1. Runs of homozygosity blocks analysis in affected dogs
showed three loci where at least 16 out of the 17 affected dogs
shared a homozygous block under the criteria applied: CFA1:
3014448-4989300 (1.97 Mb); CFA2: 69772560-71266032 (1.49
Mb); and CFA3: 93388160-94693816 (1.3Mb) (Fig. 5A, Supple-
mentary Table S5). Analysis of the genotype calls within these
TABLE 1. Top Hits (Log10(P) > 4) of GWAS in the crd1 Study
Number
i. Sort by Log10(P) ii. Sort by Location
Location* –Log10(P) Location –Log10(P)
crd1 significant SNPs and their Log10(P) values
1 93927492 5.764 93618479 4.644
2 94075783 5.764 93639445 4.644
3 94287447 5.764 93684805 5.024
4 94296622 5.764 93697691 5.384
5 94355737 5.764 93700678 5.384
6 94451861 5.764 93731523 5.384
7 94484373 5.764 93737251 5.384
8 94578249 5.715 93799182 4.663
9 94607062 5.715 93815630 4.663
10 93697691 5.384 93914980 4.663
11 93700678 5.384 93927492 5.764
12 93731523 5.384 94075783 5.764
13 93737251 5.384 94221985 4.571
14 93684805 5.024 94287447 5.764
15 93799182 4.663 94296622 5.764
16 93815630 4.663 94306027 4.663
17 93914980 4.663 94355737 5.764
18 94306027 4.663 94410234 4.663
19 94410234 4.663 94415960 4.571
20 94659212 4.663 94451861 5.764
21 94668519 4.663 94476356 4.239
22 93618479 4.644 94484373 5.764
23 93639445 4.644 94578249 5.715
24 94221985 4.571 94607062 5.715
25 94415960 4.571 94659212 4.663
26 94476356 4.239 94668519 4.663
In bold are the SNPs with the highest Log10(P) values.
* All SNPs are located on chromosome 3 (CFA3) and location is
based on CanFam 2.0.
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blocks showed that for the CFA1 locus, all affected dogs shared
the same homozygous haplotype, but that haplotype was also
observed in control dogs. At the CFA2 locus, a few
heterozygous calls were observed within the identified block.
A smaller homozygous block was observed between 70054331
and 70579965 (525.6 Kb), and for that interval the haplotype
was shared among the control dogs as well. At CFA3, 16
affected dogs shared 1.278 Mb homozygous haplotype
(93415696-94693816), and the 17th affected dog shared a
smaller interval of 1.05 Mb. This dog was not included in the
result output, since it had 88 SNPs supporting its homozygous
segment (less than 100 SNPs, one of the criteria for the run).
All the control dogs presented a different haplotype within this
segment (Supplementary Table S4A).
crd2. Runs of homozygosity blocks analysis in affected dogs
identified only one locus where all 14 affected dogs were
homozygous under the criteria of the run: CFA33: 27065615-
29382529 (2.3 Mb). This is the homozygous block bearing the
FIGURE 4. Manhattan plots summarizing results of GWAS in two canine hereditary retinal degenerations, crd1 and crd2. x-axis ¼ Canine
chromosomes 1-38, plus the X-chromosome presented as chromosomes 39 or 39 and 41. Y-axis ¼ probability statistic (log10[observed P]). (A)
crd1. Results of association analysis using PLINK software. The highestlog10(P) values are observed at the telomeric end of chromosome 3 (CFA3).
The X chromosome is represented by number 39 and 41. (B) crd2. Results of association analysis using Fisher-exact test. The highest peak is
observed on chromosome 33. A second peak at lower significance is observed on CFA12. The X chromosome is represented by the numbers 39 and
40.
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mutation, with 47 SNPs supporting that block and no
heterozygous calls (Fig. 5B, Supplementary Tables S4B, S5).
Candidate Genes Evaluation
crd1. PDE6B screening. The canine PDE6B gene is
located within the 1.05 Mb minimal homozygosity block
identified by association analysis. Mutations in this gene have
been previously identified as causing hereditary retinal
degenerations in Irish Setter18 and Sloughi dogs,19 as well as
in humans9–11 and mice.20 The gene was amplified from an
affected dog and compared with a healthy, using cDNA
prepared from retinal RNA extracts and five primer pairs
producing overlapping amplicons, covering the complete
open reading frame. Nine SNPs were observed in the coding
sequence of the gene in a healthy dog, when compared with
the National Center for Biotechnology Information (NCBI)
database mRNA sequence NM001002934 (Supplementary
Table S6). The affected dog was homozygous for the NCBI
database Boxer canine genomic reference sequence, suggest-
ing that these SNPs are not causally associated with the disease.
However, a three-bases-deletion was identified in exon 21 of
the gene in the affected dogs (c.2404-2406del, CFA3:
94574289-94574291), in-frame with the protein (Fig. 6A). This
mutation would result in a deletion of the amino acid
asparagine at position 802 of the protein (p.802del).
To evaluate whether this deletion was a result of an RNA
editing mistake, or a deletion in the DNA, primers located in
introns 20 and 21 flanking the deletion were used to amplify
genomic DNA from affected, obligate-heterozygous and healthy
dogs. Sequence confirmed the presence of this three bases
deletion in the affected genomic DNA, a deletion not observed
in the healthy dog, and the chromatogram from a heterozygous
dog showed overlapping sequence downstream from the
deletion point (data not shown).
Linkage analysis and population screening. All dogs in an
extended crd1-derived colony pedigree were genotyped for the
mutation. Complete linkage was observed between the
mutation and the disease, with a lod score of 13.847 at theta
equaled 0.00. The deletion was not found in 105 dogs from 18
different breeds not known to segregate crd1 (Supplementary
Table S1).
crd2. IQCB1 screening. Canine IQCB1 is located within
the 2.67 Mb homozygous block identified by association study.
Mutations in this gene have been identified in human patients
affected with Senior-Loken syndrome and retinitis pigmentosa
(RP).12,21 Human IQCB1 has 15 exons (NM_001023570,
transcript variant 1), 13 of which code for a 598 amino acid
long protein (NP_001018864, isoform a). Another splice
variant is reported with 12 exons (NM_001023571, transcript
variant 3) that codes for a 465 amino acid protein
(NP_001018865, isoform c). Variant 3 does not include exons
8, 9, and 10 of transcript variant 1, and was observed in
embryonic stem and melanocytes. Blasting NM_001023570
against CanFam2 identified all 15 predicted canine exons. To
evaluate the role of the gene in crd2 disease, cDNA from an
affected retina, and genomic DNA from blood of an affected
dog, were amplified and compared with healthy canine
sequence.
Reverse transcriptase PCR products from affected and
healthy retinal cDNA were assembled into a 2027 bp long
fragment and compared. The sequence comprised 85 bp
partial 50 UTR, 1797 bp of the complete coding sequence and
145 bp partial 3 0 UTR (Accession number KF366421;
Supplementary Fig. S1A). The predicted wild-type canine
IQCB1 protein is 598 amino acids long with 88.7% identity
to the human counterpart (Supplementary Fig. S1B).
A one-base insertion of cytosine in exon 10 was observed in
the affected retinal cDNA, resulting in a stretch of three
cytosines compared with two in the wild-type allele (CFA33:
28120686-28120687, Fig. 6B, red arrow; Supplementary Fig.
S1C). This insertion, c.952-953insC, causes a frame-shift that
results in a change of 12 amino acids (amino acids 319-330)
and introduction of a premature stop codon (p.S319IfsX12).
This would yield a predicted 330 amino acid protein, in which
only 318 are identical to normal (Fig. 6B; Supplementary Fig.
S1D). This deletion was also identified in genomic DNA from
an affected dog by amplifying exon 10 using primers located in
introns 9 and 10 (primer pair 10, Supplementary Table S2Bi).
Linkage analysis and population screening. A subset of
dogs from the crd2 colony-derived pedigree, plus seven
purebred dogs related to the proband (Fig. 1B, dogs 1–59)
were genotyped for the mutation. No recombination was
observed between the mutation and the disease locus and
linkage analysis gave a lod score of 11.74 at theta equals 0.0.
Dog number 2, despite having the same SNPchip genotype in
the LD interval on CFA33 as its affected offspring, genotyped
heterozygous for the IQCB1 mutation, in concordance with its
nonaffected phenotype.
A control group of 86 dogs from 17 different breeds was
genotyped for the mutation (Supplementary Table S1) and
were all homozygous for the wild-type allele.
IQCB1 mRNA expression analysis. To evaluate mRNA
expression of the IQCB1 gene in a retina affected by this
nonsense mutation, an RNA blot was generated containing
mRNA from healthy and affected retinas at selected ages, as
well as from a healthy spleen (Fig. 7). Very low levels of IQCB1
expression were detected in control retinas and only after 11
days of film exposure (Fig. 7, lanes 1, 3, 5, 7, 8). In the crd2-
affected retina there were almost undetectable levels of IQCB1
at the three ages evaluated: 2.9 weeks, 5.0 weeks, and 12.3
weeks (Fig. 7, lanes 2, 4, 6). IQCB1 was not detected in the
spleen. Beta actin shows insignificant variation in loading
TABLE 2. Top hits (Log10(P) > 4) of GWAS in the crd2 Study
Number
i. Sort by Log10(P) ii. Sort by Location
Location* –Log10(P) Location –Log10(P)
crd2 significant SNPs and their Log10(P) values
1 Chr33. 22690750 6.126 Chr12. 3464390 4.172
2 Chr33. 24438552 6.126 Chr12. 3865659 4.162
3 Chr33. 24438637 6.126 Chr33. 21465360 4.470
4 Chr33. 24885473 6.126 Chr33. 22690750 6.126
5 Chr33. 27122415 6.126 Chr33. 23215781 4.152
6 Chr33. 29049963 5.469 Chr33. 23804255 4.470
7 Chr33. 29860172 5.223 Chr33. 23882615 4.470
8 Chr33. 30531791 5.008 Chr33. 24438552 6.126
9 Chr33. 30378609 4.703 Chr33. 24438637 6.126
10 Chr33. 21465360 4.470 Chr33. 24478407 4.470
11 Chr33. 23804255 4.470 Chr33. 24564448 4.470
12 Chr33. 23882615 4.470 Chr33. 24574669 4.470
13 Chr33. 24478407 4.470 Chr33. 24885473 6.126
14 Chr33. 24564448 4.470 Chr33. 27122415 6.126
15 Chr33. 24574669 4.470 Chr33. 28668552 4.172
16 Chr12. 3464390 4.172 Chr33. 28882337 4.152
17 Chr33. 28668552 4.172 Chr33. 29049963 5.469
18 Chr12. 3865659 4.162 Chr33. 29860172 5.223
19 Chr33. 30517730 4.162 Chr33. 30378609 4.703
20 Chr33. 23215781 4.152 Chr33. 30517730 4.162
21 Chr33. 28882337 4.152 Chr33. 30531791 5.008
In bold are the SNPs with the highest Log10(P) values.
* Location is based on CanFam 2.0.
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quantity among the retinal samples. This suggests that mutant
IQCB1 mRNA is degraded and presumably by nonsense-
mediated decay.
DISCUSSION
Genome-wide association studies have a wide range of
application, from simple mendelian traits, to complex, within
isolated populations and in more diverse cohorts, in humans
and in animals.22–31 In the second quarter of 2012 only, 1350
studies were published with GWAS results at P values equal or
lower than 5 3 108 (available in the public domain at www.
genome.gov/gwastudies).
Canine populations mimic human isolates in their small,
closed gene pools, resulting in a more homogenous genome
and larger LD blocks within each breed, making them ideally
suited for mapping disease-causative genes.17,32–35 Previously,
we mapped by GWAS the gene responsible for crd3, a late
onset cone–rod dystrophy segregating in the Irish Glen of
Imaal Terrier breed of dog.36 In the current study, we mapped
by GWAS the loci for two nonallelic but phenotypically similar
diseases in two closely related breeds, in each study utilizing
fewer than 20 dogs per case and control group, and exploiting
mixed-breed colony-derived pedigrees.
The first disease, crd1, mapped to chromosome 3, enabling
a mutation in PDE6B to be identified. The second, crd2,
mapped to chromosome 33, and a mutation in IQCB1 was
FIGURE 5. Schematic illustration of results of homozygosity block analysis on crd1 and crd2 disease implicated chromosomes. (A) crd1. Seventeen
affected dogs (y-axis) were analyzed to identify homozygous blocks larger than 1 Mb. Horizontal black bars represent homozygous blocks observed
on chromosome 3 (x-axis). The grey-shaded vertical box (far right) shows where 16 dogs share a homozygous block. Dog number 17 shares this
same region as well, but is not represented here with a horizontal black bar since its block was supported by less than 100 SNPs, one of the criteria
used in the analysis. (B) crd2. Fourteen affected dogs (y-axis) were analyzed to identify homozygous blocks larger than 1 Mb. Horizontal black bars
represent the homozygous blocks observed on chromosome 33 (x-axis). The grey shaded vertical box shows where all 14 dogs share a homozygous
block.
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identified. Though the diseases show similar pathology, albeit
with some differences in detail, the responsible genes are in
two different pathways, and are expressed in different
compartments of the photoreceptor cell: PDE6B in the rod
photoreceptor OS, and IQCB1 in the connecting cilium.
PDE6B codes for one of the three subunits (alpha, beta,
gamma in 1:1:2 ratio) required to assemble the heterotetra-
meric protein PDE6, a rod-specific essential component of the
visual cascade. PDE6 mediates hydrolysis of cyclic guanine
monophosphate (cGMP), closing ionic channels gated by
cGMP and eventually generating a visual signal. Thus, cGMP-
PDE is pivotal in phototransduction.37 This newly identified
canine PDE6B mutation, a three-bases in-frame deletion, would
produce a one amino acid deletion in the catalytic domain of
the PDE6B protein (position 802, Fig. 8A, yellow arrow head).
This amino acid is part of the enzyme activity domain
PDEase_I-pfam00233, which starts at amino acid 556 and ends
at amino acid 804 (Fig. 8A, green box). The deleted amino acid
is highly conserved among species (Fig. 8B) and further
domain conservation analysis suggests that the presence of an
amino acid at this position is highly conserved as well (data not
shown).
At least 25 different PDE6B mutations have been identified
in humans and these account for approximately 4.5% of all
autosomal recessive RPs (arRPs) in the United States.11 Most of
those mutations are missense mutations, and although the
downstream effect of these types of mutations has not been
fully characterized, they may change the enzyme’s function
rather than eliminate it as nonsense mutations do. Since the
type of mutation can influence the mode of inheritance, age of
onset, rate of progression, and efficiency of gene therapy for
the disease, it is important to identify animal models that
harbor similar types of mutations to those found in human
patients. Several mouse models for PDE6B deficiency are
FIGURE 6. Normal and affected chromatograms for crd1 and crd2 diseases. Each codon within the open reading frame is translated to its amino acid
as denoted by a letter above or under the chromatogram. (A) The upper chromatogram is the normal canine sequence for part of PDE6B. In red and
bold are the amino acids (NN) corresponding to codons 802 and 803 (N¼ asparagine). Boxed are the six bases corresponding to these two codons
(AACAAC). The lower chromatogram is the corresponding sequence from a crd1-affected dog. Only one AAC codon is observed at position 802-803
(boxed), which translates to an in-frame protein with one amino acid deletion (only one asparagine, labeled in bold and red). (B) The upper
chromatogram is the normal canine sequence for part of IQCB1. The lower chromatogram is the corresponding sequence from a crd2-affected dog.
A cytosine insertion is observed (red arrow), resulting in a stretch of three cytosines compared with two in the healthy dog. This results in a frame-
shift, changing 12 amino acids (colored in red and bold), followed by a premature stop codon TAA (p.S319IfsX12).
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available. The rd1 mouse is homozygous for a PDE6B nonsense
mutation and presents as a very early onset and rapid disease,
with rod photoreceptor degeneration beginning by approxi-
mately 8-days postnatal, and complete by 4 weeks of age with
no then remaining photoreceptors. On the other hand, rd10
mice, homozygous for a missense mutation in exon 13
(Arg560Cys) are affected with slower rod photoreceptor
degeneration, beginning at 16 days of age in the central retina
and at 20 days in peripheral retina, and proceeding to death of
all photoreceptors by 60 days of age. Histologic analysis
comparing rd1 and rd10 shows four ONL in rd10 mice
compared with zero in rd1 at 24 days of age. In complemen-
tation testing, all F1 (rd1 x rd10) progeny were affected at an
early age and identical in retinal appearance to rd1 at 66 days.
The rd10 model is, thus, of great value for early-stage
theraputic testing, balancing a significant retinal pathology
with a slower rate of progression, and, thus, an enhanced
opportunity to achieve rescue of cells.
The PDE6B mutation in crd1 dogs does not introduce a
premature stop codon, as the three bases deletion is in-frame
with the open reading frame, resulting in a one amino acid
deletion (Fig. 8B). In contrast, the PDE6B mutation observed in
rcd1 dogs is a nonsense mutation in codon 807 (Fig. 8B, circled
W), just five amino acids downstream from the position of the
crd1 mutation, and results in a protein truncated by 49 amino
acids, and complete loss of enzyme function.18 We suggest that
the two canine diseases, rcd1 and crd1, correspond to the rd1
and rd10 mouse models, respectively, in terms of the type of
mutation, phenotype, age of onset, rate of progression, and the
potential for gene therapy. Both rcd1 and rd1 have a nonsense
mutation, while crd1 and rd10 do not, and no premature stop
codon is introduced as a result of the latter two mutations.
Functional assays showed complete loss-of-function in both
rcd1 and rd1. In both, rod photoreceptor degeneration is early
and fast. In contradistinction, crd1 affected dogs and rd10
mice show a relatively slower progression of cell death and
offer important advantages for evaluating gene therapies
particularly for human RP caused by missense rather than null
PDE6B mutations.
Though phenotypically crd2 is very similar to crd1 disease,
the genetic mutations underlying the two diseases were
different. By genome-wide association we were able to identify
the locus for canine crd2 on chromosome 33, to a 2.67 Mb
interval. The use of obligate heterozygotes as a control group
reduced the association signal, but did not change the ability to
identify the causative locus. The usage of the broader colony-
derived pedigree was essential to distinguish between the false
positive association signal (hit on CFA12) and real positive hits
(hit on CFA33). This emphasizes the importance of informative
pedigrees to better evaluate statistics results, or to better
prioritize loci if identified by a homozygosity approach.
Interestingly, one purebred obligate carrier had genotype calls
identical to its purebred affected offspring at the disease locus
that extended over an 18 Mb interval (dog number 15,
Supplementary Table S4). This suggests that when a mutation
arises on a chromosome with a haplotype that is widespread in
a population of limited diversity, the resolution of the SNPchip
array can be limited, and GWAS challenging, particularly if only
closely related individuals are available for the study.
The gene IQCB1, identified herein as mutated in canine
crd2, codes for one member of a group of up to 13 different
ciliary proteins collectively called Nephronophthisis (NPHP)
proteins.38 Mutant NPHP proteins cause a broad spectrum of
diseases collectively termed ciliopathies and characterized by
pathologies including renal cysts, liver fibrosis, and retinal
degeneration and others.38,39
Mutations in IQCB1 (NPHP5) consistently cause retinal
disease, as is also the case for CEP290 (NPHP6).40 Eleven
different mutations in IQCB1, all of which resulted in a
predicted truncated protein, were identified in human patients
with Senior-Loken syndrome (SLSN) a disorder including both
nephronophthisis and RP, whereas IQCB1 mutations were not
found in other nephronophthisis patients without RP12,21
(available in the public domain at http://www.hgmd.org).
Plausible disease-causing genotypes in IQCB1 were identified
in nine patients affected by Leber congenital amaurosis (LCA)
without nephrononphthisis.14 These patients suffer from
significant vision loss and nystagmus in the first few months
of life. None exhibited evidence of renal disease in the first
decade of life but two were diagnosed with NPHP at age 13
years. Similar results were reported in a different cohort of LCA
patients from The Netherlands, with frame-shift and nonsense
IQCB1 mutations identified in 11 patients, and a highly variable
onset of renal failure.13 Nonophthalmologic problems consis-
tent with a ciliopathy were not observed and have not been
reported in crd2-affected dogs. Similarly, in the standard wire-
haired dachshund breed of dog, where a mutation in NPHP4
has been causally associated with a cone–rod dystrophy, no
kidney involvement is reported.41 However, in both these
diseases, careful evaluation of older dogs is clearly warranted.
The IQCB1 protein interacts with calmodulin and the RP
GTPase regulator (RPGR) protein. The encoded protein has a
central coiled-coil region and four IQ domains: coil–coil
domain (aa 336-362); IQ1 (aa 294-317), IQ2 (aa 318-338),
IQ3 (aa 387-416), IQ4 (aa 417-437). It is localized to the
primary cilia of renal epithelial cells and connecting cilia of
photoreceptor cells. The canine insertional mutation in exon
10 of IQCB1 results in a frame-shift and a premature stop
codon 39 bases after the insertion. RNA expression analysis
suggests that the mutated RNA is degraded in the affected
retina, and therefore the protein is not transcribed. If any RNA
escapes the degradation by nonsense-mediated decay, the
predicted protein would have only the first 318 amino acids,
missing IQ2, IQ3, and IQ4 domains, and the coiled-coil domain.
The reported human mutations are similar in that that all of
them are nonsense mutations or small insertions or deletions
resulting in a premature stop codon and a predicted truncated
protein. Most of these mutations would result in the absent of
one of the IQ domains or the coiled-coil domain. The 88.7%
FIGURE 7. Northern blot demonstrating IQCB1 RNA expression in
healthy and crd2-affected retina at specific ages. In samples from
healthy retinas (N; lanes 1, 3, 5, 7, 8), low levels of IQCB1 mRNA are
detected after 11 days of film exposure at all ages tested (3.3-weeks old,
lane 1; 4.3-weeks old, lane 3; 12-weeks old, lane 5; 10.4-weeks old,
lane 7; 8.6-weeks old, lane 8). In samples from crd2-affected retinas (A;
lanes 2, 4, 6) IQCB1 expression is almost undetectable at the three
different time-points evaluated (2.9-weeks old, lane 2; 5-weeks old,
lane 4; and 12.3-weeks old, lane 6). No IQCB1 RNA was detected in a
sample from 22-weeks-old healthy spleen (lane 9). Beta-actin control
shows insignificant variation in loading quantity among the retinal
samples.
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homology between the dog and human IQCB1 proteins
(Supplementary Fig. S2) further supports canine crd2 disease
as a valuable model for SLSN and LCA diseases.
Ciliopathies feature a broad spectrum of organ involvement.
It has recently become evident that the spectrum can vary by
at least two mechanisms: multiple allelism and modifiers. For
example, a polymorphic coding variant of RPGRIP1L (NPHP8)
was found to be associated with the development of retinal
degeneration in patients with ciliopathies caused by mutations
in other genes42; NPHP6 and AHl1 modify recessive NPHP1
mutations to express a more severe phenotype.43 Stone et al.14
showed that although all patients had seemingly similar disease
alleles in that they were all nonsense mutations or frame-shifts,
which might reasonably be expected to result in complete loss
of function of the protein, variation in disease phenotype was
still observed. One explanation might be the effect of genetic
background, that is, variations in other genes that do not
themselves adversely affect an individual’s phenotype, but do
alter the pathogenicity of a disease-causing allele. Future
studies on the crd2 canine model might shed light on those
genetic alleles and their effect on the renal involvement in this
disease.
Stone and his group had also shown, by optical coherence
tomography (OCT) imaging (Fourier-domain OCT system,
RTVue-100; Optovue, Inc., Fremont, CA), partial preservation
of foveal photoreceptors in two patients with IQCB1
mutations.14 This is especially encouraging for future thera-
peutic interventions. In young crd2-affected dogs retina also,
the temporal quadrant tends to preferentially develop and
preserve photoreceptors. The crd2-dog, thus, has significant
appeal as a model for gene-therapy of SLSN and LCA diseases
caused by IQCB1 mutations, and a valuable complement to the
rd16;Nrl/ double-mutant mouse model.44
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